N,n-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the same and uses thereof in the preparation of medicaments
The present invention provides compounds of Formula (I) that act as glucokinase activators pharmaceutical compositions thereof and methods of treating diseases, disorders, or conditions mediated by glucokinase.La présente invention concerne des composés de formule (I) qui agissent comme activateurs de la glucokinase. Linvention concerne également des compositions pharmaceutiques comprenant ceux-ci et des procédés de traitement de maladies, de troubles, ou détats pathologiques induits par la glucokinase.
